infectious laryngotracheitis virus
GPTKB entity
Statements (53)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:avian_coronavirus
|
gptkbp:affects |
chickens
|
gptkbp:caused_by |
infectious laryngotracheitis
|
gptkbp:clinical_trial |
gptkb:historical_event
nutritional support conjunctivitis environmental sanitation isolation of affected birds reduced egg production |
gptkbp:controls |
educational outreach
vaccination programs quarantine monitoring and surveillance biosecurity practices culling infected birds |
gptkbp:distribution |
worldwide
|
gptkbp:economic_impact |
poultry industry
|
gptkbp:excretion |
feces
ocular secretions respiratory secretions |
gptkbp:family |
gptkb:Herpesviridae
|
gptkbp:genus |
Iltovirus
|
gptkbp:has_feature |
enveloped virus
|
gptkbp:hosts |
gptkb:bird
|
https://www.w3.org/2000/01/rdf-schema#label |
infectious laryngotracheitis virus
|
gptkbp:is_protected_by |
vaccination
|
gptkbp:is_recognized_by |
1930s
|
gptkbp:is_vulnerable_to |
inactivated vaccine
live attenuated vaccine reduces transmission reduces clinical signs reduces mortality |
gptkbp:research_focus |
vaccine development
epidemiology studies pathogenesis studies |
gptkbp:seed_dispersal |
double-stranded DNA
|
gptkbp:social_responsibility |
serological tests
highly pathogenic PCR testing avian influenza Newcastle disease |
gptkbp:symptoms |
difficulty breathing
coughing nasal discharge swelling of the head |
gptkbp:transmission |
direct contact
aerosol fomites |
gptkbp:treatment |
supportive care
anti-inflammatory drugs antibiotics for secondary infections |